These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
867 related articles for article (PubMed ID: 10477777)
1. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777 [TBL] [Abstract][Full Text] [Related]
2. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. Bergqvist D; Agnelli G; Cohen AT; Eldor A; Nilsson PE; Le Moigne-Amrani A; Dietrich-Neto F; N Engl J Med; 2002 Mar; 346(13):975-80. PubMed ID: 11919306 [TBL] [Abstract][Full Text] [Related]
3. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538 [TBL] [Abstract][Full Text] [Related]
4. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. Bauer KA; Eriksson BI; Lassen MR; Turpie AG; N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149 [TBL] [Abstract][Full Text] [Related]
5. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. Eriksson BI; Bauer KA; Lassen MR; Turpie AG; N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148 [TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ; Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368 [TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W; N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811 [TBL] [Abstract][Full Text] [Related]
8. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. Goldhaber SZ; Leizorovicz A; Kakkar AK; Haas SK; Merli G; Knabb RM; Weitz JI; N Engl J Med; 2011 Dec; 365(23):2167-77. PubMed ID: 22077144 [TBL] [Abstract][Full Text] [Related]
9. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG; N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812 [TBL] [Abstract][Full Text] [Related]
11. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. Turpie AG; Gallus AS; Hoek JA; N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275 [TBL] [Abstract][Full Text] [Related]
12. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. Schulman S; Wåhlander K; Lundström T; Clason SB; Eriksson H; N Engl J Med; 2003 Oct; 349(18):1713-21. PubMed ID: 14585939 [TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V; N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M; N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587 [TBL] [Abstract][Full Text] [Related]
17. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Eriksson BI; Lassen MR; Arch Intern Med; 2003 Jun; 163(11):1337-42. PubMed ID: 12796070 [TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin and mortality in acutely ill medical patients. Kakkar AK; Cimminiello C; Goldhaber SZ; Parakh R; Wang C; Bergmann JF; N Engl J Med; 2011 Dec; 365(26):2463-72. PubMed ID: 22204723 [TBL] [Abstract][Full Text] [Related]
19. Electronic alerts to prevent venous thromboembolism among hospitalized patients. Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007 [TBL] [Abstract][Full Text] [Related]
20. Enoxaparin for the prevention of VT in acutely ill patients. Tseng CW; Huntington J J Fam Pract; 1999 Dec; 48(12):940-1. PubMed ID: 10628571 [No Abstract] [Full Text] [Related] [Next] [New Search]